K Pharma (TSE:4896) Notes Receivable: 円0.00 Mil (As of Dec. 2025)


TSE:4896 K Pharma Inc TSE:4896
11 GF Score
Price 円699.00
! 1 Warning Sign
View Full Analysis

What is K Pharma Notes Receivable?

K Pharma TSE:4896 -1.13% 11 Notes Receivable is 円0.00 Mil as of Dec. 2025. GuruFocus rates TSE:4896 with a GF Score™ of 11/100. The stock has 1 warning sign investors should review.

K Pharma's Notes Receivable for the quarter that ended in Dec. 2025 was 円0.00 Mil.

K Pharma Notes Receivable Historical Data

* Premium members only.

The historical data trend for K Pharma's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

K Pharma Notes Receivable Chart

K Pharma Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Notes Receivable
0.00 0.00 0.00 0.00 0.00

K Pharma Quarterly Data
Dec21 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:4896
11GF Score
K Pharma Inc TSE:4896
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

K Pharma Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of 円0.00 Mil mean?
K Pharma (TSE:4896) has a Notes Receivable of 円0.00 Mil as of Dec. 2025. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on K Pharma and its competitors.
Is K Pharma's Notes Receivable too high?
K Pharma's current Notes Receivable is 円0.00 Mil. Overall, K Pharma has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does K Pharma's Notes Receivable compare to VRTX and REGN?
K Pharma's Notes Receivable of 円0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Biotechnology company?
A good Notes Receivable depends on the Biotechnology industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on K Pharma and its competitors. K Pharma's current Notes Receivable is 円0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is K Pharma stock overvalued right now?
K Pharma (TSE:4896) has a current Notes Receivable of 円0.00 Mil. The current Notes Receivable is 円0.00 Mil. K Pharma's overall GF Score™ is 11/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For K Pharma (TSE:4896), the current Notes Receivable is 円0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

K Pharma Business Description

Address 7-7-7 Roppongi, Tri-Seven Roppongi 8th Floor, Minato-ku, Tokyo, JPN, 106-0032
K Pharma Inc is a company involved in Research, development, manufacturing, sales, and marketing of pharmaceutical products and regenerative medicine products. It is involved in the study of iPs cells in regenerative medicine to treat neurological conditions such as cerebral infarction and SCI.
11GF Score

Get the complete analysis for TSE:4896

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円699.00
Price